Terug
Dagbereik
€ 177,84
€ 178,80
52-Weeksbereik
€ 125,94
€ 178,87
Volume
1.587.309
50D / 200D Gem.
€ 155,89
/
€ 150,88
Vorige Slotkoers
€ 178,44
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -63,4 | 0,3 |
| P/B | 13,3 | 2,9 |
| ROE % | -17,1 | 3,7 |
| Net Margin % | -9,9 | 3,8 |
| Rev Growth 5Y % | 5,4 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 187,50
+4.9%
Low: € 180,00
High: € 200,00
Forward K/W
32,5
Forward WPA
€ 5,50
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,5 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 7,43
€ 7,37 – € 7,49
|
2 B | 1 |
| FY2029 |
€ 7,43
€ 7,37 – € 7,49
|
1,9 B | 1 |
| FY2028 |
€ 6,66
€ 6,37 – € 7,18
|
1,7 B | 6 |
Belangrijkste Punten
Revenue grew 5,36% annually over 5 years — modest growth
Generating 197,80M in free cash flow
PEG of 0,89 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 32,46%
Capital efficient — spends only 1,27% of revenue on capex
ROIC of 18,32% — excellent capital efficiency
Groei
Revenue Growth (5Y)
5,36%
Revenue (1Y)-27,10%
Earnings (1Y)N/A
FCF Growth (3Y)455,93%
Kwaliteit
Return on Equity
-17,09%
ROIC18,32%
Net Margin-9,92%
Op. Margin20,49%
Veiligheid
Debt / Equity
0,78
Current Ratio2,49
Interest Coverage9,42
Waardering
P/E Ratio
-63,35
P/B Ratio13,31
EV/EBITDA31,99
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -27,10% | Revenue Growth (3Y) | -13,66% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5,36% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,53B | Net Income (TTM) | -151,50M |
| ROE | -17,09% | ROA | -8,92% |
| Gross Margin | 61,90% | Operating Margin | 20,49% |
| Net Margin | -9,92% | Free Cash Flow (TTM) | 197,80M |
| ROIC | 18,32% | FCF Growth (3Y) | 455,93% |
| Safety | |||
| Debt / Equity | 0,78 | Current Ratio | 2,49 |
| Interest Coverage | 9,42 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -63,35 | P/B Ratio | 13,31 |
| P/S Ratio | 6,29 | PEG Ratio | 0,89 |
| EV/EBITDA | 31,99 | Dividend Yield | 0,00% |
| Market Cap | 9,60B | Enterprise Value | 10,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,53B | 2,09B | 2,05B | 2,04B | 1,24B |
| Net Income | -151,50M | -304,90M | 81,50M | 143,50M | 229,60M |
| EPS (Diluted) | -2,80 | -5,72 | 1,51 | 2,60 | 3,98 |
| Gross Profit | 945,20M | 1,00B | 1,00B | 1,06B | 808,40M |
| Operating Income | 312,80M | -266,70M | 136,50M | 210,00M | 275,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,70B | 2,63B | 3,04B | 3,21B | 1,89B |
| Total Liabilities | 977,70M | 1,57B | 1,68B | 1,87B | 336,80M |
| Shareholders' Equity | 721,20M | 1,05B | 1,36B | 1,34B | 1,55B |
| Total Debt | 559,30M | 846,10M | 970,00M | 1,03B | 32,70M |
| Cash & Equivalents | 152,30M | 177,60M | 163,00M | 202,90M | 745,30M |
| Current Assets | 926,00M | 1,23B | 1,23B | 1,31B | 1,24B |
| Current Liabilities | 371,60M | 617,70M | 563,80M | 630,00M | 267,70M |